Member Profile

Established in 1998, with robust growth of revenue, profit and marketing channel, TCM Biotech International Corp. is a biotech company specializing in innovative research and development of new drug and as the second company ratified by Taiwan’s Ministry of Economic Affairs to be a “Biotechnology New Drug Company” for the remarkable R&D capability and achievement. With TQF certification “Medical Fungi Fermentation Factory” was established in Tainan Hsin-Ying Industrial Park mainly responsible for the providing the required principal active ingredient for the health supplements development.

This company focuses on the development of new drug and diagnosis for the prevention and treatment of liver disease as its product development spindle: PTX-9908 combined with TACE for liver cancer, Liver cancer early detection test “CatCHimera “circulating ctDNA biomarker for HCC and comprehensive patent-layout. In addition to the establishment of Taiwan’s professional marketing team, it’s also strategically in alliance with China partners to build up the marketing channel network, gradually expand to international market and then well-applying of revenue profit into the development of specialty products and new drug. Furthermore, it’s showed that the R&D capacity of this company has been recognized by government for the subsidization support during pre-clinical and clinical trial stage of new drug development.

Looking ahead, TCM Biotech will turn into an international biotech company professional in the R&D, manufacturing and marketing of new drug in prevention and treatment of liver disease. And well utilize the advantage of channel, product feature, completion strength to bring in maximum revenue and profit as goal.